Medherant Ltd - Product Pipeline Analysis, 2018 Update

Medherant Ltd - Product Pipeline Analysis, 2018 Update

  • Products Id :- GDME2442628PD
  • |
  • Pages: 24
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary


Medherant Ltd (Medherant) is a transdermal drug delivery patch company. The company develops and commercializes novel technologies for delivery of drugs through the skin using expertise in bioadhesives and polymer chemistry to treat pain, Alzheimer's disease, and for smoking cessation, hormone therapy, and others. Its TEPI patch technology enables the production of patches with effective doses of active ingredients with enhanced long-term drug delivery. Medherant provides high drug loading patches for ibuprofen transdermal and methyl salicylate delivery. The company works in partnership with other companies such as AdhexPharma and Bostik to manufacture TEPI Patch products. It is a spinoff of the University of Warwick. Medherant is headquartered in Coventry, the UK.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Medherant Ltd

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Medherant Ltd Company Overview 4

Medherant Ltd Company Snapshot 4

Medherant Ltd Pipeline Products and Ongoing Clinical Trials Overview 4

Medherant Ltd-Pipeline Analysis Overview 6

Medherant Ltd-Key Facts 6

Medherant Ltd-Major Products and Services 7

Medherant Ltd Pipeline Products by Development Stage 8

Medherant Ltd Pipeline Products Overview 9

Ibuprofen TEPI Patch 9

Ibuprofen TEPI Patch Product Overview 9

Lidocaine TEPI Patch 10

Lidocaine TEPI Patch Product Overview 10

Methyl Salicylate TEPI Patch 11

Methyl Salicylate TEPI Patch Product Overview 11

Medherant Ltd-Key Competitors 12

Medherant Ltd-Key Employees 13

Medherant Ltd-Locations And Subsidiaries 14

Head Office 14

Recent Developments 15

Medherant Ltd, Recent Developments 15

Mar 07, 2018: Medherant expands team with appointment of David Davies as Head of Development 15

Nov 17, 2017: Medherant wins Excellence in Science & Technology Award 15

Oct 18, 2017: Warwick graduate invents revolutionary device for testing drugs 16

Sep 26, 2017: Medherant Signs Agreement with Leading Japanese Transdermal Patch Company for Evaluation of Its TEPI Patch Drug Delivery System 17

Jun 26, 2017: Medherant appoints new COO and CFO 17

Jun 26, 2017: Medherant expands management team with appointment of Sally Waterman, COO and Angus Hone, CFO 18

Jun 06, 2017: Medherant Appoints Sheryl Caswell to Lead Clinical Development of Products Based on its Revolutionary TEPI Patch 18

May 08, 2017: Medherant Appoints Laboratoires Plasto Sante as Transdermal Drug Delivery Patch Manufacturer 19

Feb 06, 2017: Medherant Announces Appointment of New Chair 19

Feb 22, 2016: Medherant's First Ibuprofen Patch-TEPI Patch Technology 20

Appendix 21

Methodology 21

About GlobalData 24

Contact Us 24

Disclaimer 24

List of Figures

Medherant Ltd Pipeline Products by Equipment Type 5

Medherant Ltd Pipeline Products by Development Stage 8

List of Tables

Medherant Ltd Pipeline Products and Ongoing Clinical Trials Overview 4

Medherant Ltd Pipeline Products by Equipment Type 5

Medherant Ltd Pipeline Products by Indication 5

Medherant Ltd, Key Facts 6

Medherant Ltd, Major Products and Services 7

Medherant Ltd Number of Pipeline Products by Development Stage 8

Medherant Ltd Pipeline Products Summary by Development Stage 8

Ibuprofen TEPI Patch-Product Status 9

Ibuprofen TEPI Patch-Product Description 9

Lidocaine TEPI Patch-Product Status 10

Lidocaine TEPI Patch-Product Description 10

Methyl Salicylate TEPI Patch-Product Status 11

Methyl Salicylate TEPI Patch-Product Description 11

Medherant Ltd, Key Employees 13

Glossary 23

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

Nemaura Pharma Ltd

3M Health Care Ltd

MedPharm Ltd

Medherant Ltd,Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 51465
Site License
USD 1500 INR 102930
Corporate User License
USD 2250 INR 154395



The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]